Flexion Therapeutics (Boston Mass.)
In June of 2017 we were thrilled to win the contract for a variety of video projects for the launch of Flexion Therapeutics, and their novel new product Zilretta. Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis. Flexion’s co-founders, Dr. Clayman and Dr. Bodick have significant capability, developed during their combined 35 years at Eli Lilly and Company, in both rapidly progressing new drugs to meaningful clinical proof of concept and in conducting successful pivotal clinical programs leading to regulatory submissions. Zilretta received FDA approval in October 2017. This video is used as an introduction to the company and its history and culture for newly hired reps.

Share Project :

  • Categories:
  • Share Project :